Detalhe da pesquisa
1.
B cell characteristics define HCV reinfection outcome.
J Hepatol
; 2024 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38604387
2.
Interleukin-17 contributes to Ross River virus-induced arthritis and myositis.
PLoS Pathog
; 18(2): e1010185, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35143591
3.
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.
J Viral Hepat
; 31(1): 21-34, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37936544
4.
Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes.
J Med Virol
; 96(1): e29381, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38235622
5.
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial.
Brain Behav Immun
; 115: 191-200, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37848096
6.
Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Immunol
; 209(8): 1499-1512, 2022 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36165172
7.
Trends in intravenous immunoglobulin use in New South Wales, Australia.
Intern Med J
; 54(1): 149-156, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37488980
8.
A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study.
J Hepatol
; 79(3): 635-644, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37116714
9.
High activation levels maintained in receptor-binding domain-specific memory B cells in people with severe coronavirus disease 2019.
Immunol Cell Biol
; 101(2): 142-155, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36353774
10.
Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study.
Liver Int
; 43(3): 569-579, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36305315
11.
Consensus recommendations on the management of hepatitis C in Australia's prisons.
Med J Aust
; 218(5): 231-237, 2023 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36871200
12.
Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study.
Clin Infect Dis
; 75(10): 1809-1819, 2022 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35362522
13.
Human CD8 T-stem cell memory subsets phenotypic and functional characterization are defined by expression of CD122 or CXCR3.
Eur J Immunol
; 51(7): 1732-1747, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33844287
14.
Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in Prisons.
Hepatology
; 74(5): 2366-2379, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34105797
15.
Regulation of the Acute Sickness Response by the P2RX7 Receptor.
J Infect Dis
; 224(5): 914-920, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33471105
16.
Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants.
BMC Genomics
; 22(1): 148, 2021 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33653280
17.
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design.
PLoS Pathog
; 15(5): e1007772, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31100098
18.
The severity of the pathogen-induced acute sickness response is affected by polymorphisms in genes of the NLRP3 inflammasome pathway.
Brain Behav Immun
; 93: 186-193, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33434563
19.
Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection.
Clin Infect Dis
; 70(1): 123-131, 2020 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30816419
20.
B cell immunodominance in primary hepatitis C virus infection.
J Hepatol
; 72(4): 670-679, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31785346